Nimbus Wadjet, Inc.

Nathan E Genung

Derun Li

Silvana Marcel Leit De Moradei

Angela V West

Nikolay Sitnikov

Florian Bartels

The present disclosure is directed to compounds of Formula I: and pharmaceutically acceptable salts thereof, and compositions thereof, as well as methods of treatment of cancers such as those involving WRN protein.

WRN inhibitors

The present disclosure is directed to compounds of Formula II-e: and pharmaceutically acceptable salts thereof, and compositions thereof, as well as methods of treatment of cancers such as those involving WRN protein.

Growing community of inventors

Boston, MA, United States of America

Nathan E Genung